Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients

The purpose of this study was to examine prognostic value of T1- and T2-mapping techniques in heart transplant patients. Myocardial characterization using T2 mapping (evaluation of edema/inflammation) and pre- and post-gadolinium contrast T1 mapping (calculation of extracellular volume fraction [ECV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Cardiovascular imaging 2020-07, Vol.13 (7), p.1521-1530
Hauptverfasser: Chaikriangkrai, Kongkiat, Abbasi, Muhannad Aboud, Sarnari, Roberto, Dolan, Ryan, Lee, Daniel, Anderson, Allen S., Ghafourian, Kambiz, Khan, Sadiya S., Vorovich, Esther E., Rich, Jonathan D., Wilcox, Jane E., Blaisdell, Julie A., Yancy, Clyde W., Carr, James, Markl, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The purpose of this study was to examine prognostic value of T1- and T2-mapping techniques in heart transplant patients. Myocardial characterization using T2 mapping (evaluation of edema/inflammation) and pre- and post-gadolinium contrast T1 mapping (calculation of extracellular volume fraction [ECV] for assessment of interstitial expansion/fibrosis) are emerging modalities that have been investigated in various cardiomyopathies. A total of 99 heart transplant patients underwent the magnetic resonance imaging (MRI) scans including T1- (n = 90) and T2-mapping (n = 79) techniques. Relevant clinical characteristics, MRI parameters including late gadolinium enhancement (LGE), and invasive hemodynamics were collected. Median clinical follow-up duration after the baseline scan was 2.4 to 3.5 years. Clinical outcomes include cardiac events (cardiac death, myocardial infarction, coronary revascularization, and heart failure hospitalization), noncardiac death and noncardiac hospitalization. Overall, the global native T1, postcontrast T1, ECV, and T2 were 1,030 ± 56 ms, 458 ± 84 ms, 27 ± 4% and 50 ± 4 ms, respectively. Top-tercile-range ECV (ECV >29%) independently predicted adverse clinical outcomes compared with bottom-tercile-range ECV (ECV 
ISSN:1936-878X
1876-7591
DOI:10.1016/j.jcmg.2020.01.014